In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programs
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a devastating condition characterized by progressive lung function decline and early mortality. While early accurate diagnosis is essential for IPF treatment, data evaluating the impact of hospital academic status on IPF-related mortality re...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-11-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12890-020-01328-y |
id |
doaj-97a52bc00d3448069c246698ba0f35f4 |
---|---|
record_format |
Article |
spelling |
doaj-97a52bc00d3448069c246698ba0f35f42020-11-25T04:07:01ZengBMCBMC Pulmonary Medicine1471-24662020-11-0120111110.1186/s12890-020-01328-yIn-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programsShehabaldin Alqalyoobi0Evans R. Fernández Pérez1Justin M. Oldham2Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, East Carolina University-Brody School of MedicineDivision of Pulmonary, Critical Care and Sleep Medicine, National Jewish HealthDepartment of Internal Medicine; Division of Pulmonary, Critical Care and Sleep Medicine, University of California at DavisAbstract Background Idiopathic pulmonary fibrosis (IPF) is a devastating condition characterized by progressive lung function decline and early mortality. While early accurate diagnosis is essential for IPF treatment, data evaluating the impact of hospital academic status on IPF-related mortality remains limited. Here we examined in-hospital mortality trends for patients with IPF from 2013 to 2017. We hypothesized that in-hospital IPF mortality would be influenced by hospital academic setting. Methods Hospitalization data was extracted from the National Inpatient Sample (NIS) for subjects with an international classification of disease code for IPF. In-hospital mortality stratified by hospital setting (academic versus non-academic) was the primary outcome of interest, with secondary analyses performed for subgroups with and without respiratory failure and requiring mechanical ventilation. Predictors of mortality were then assessed. Results Among 93,680 patients with IPF requiring hospitalization, 58,450 (62.4%) were admitted to academic institutions. In-hospital mortality decreased significantly in those admitted to an academic hospital (p < 0.001) but remained unchanged in patients admitted to a non-academic hospital. A plateau in-hospital mortality was observed among all hospitalized patients (p = 0.12), with a significant decrease observed for patients with admitted respiratory failure (p < 0.001) and those placed on mechanic ventilation (p < 0.001). Conclusion In-hospital mortality decreased significantly for patients with IPF admitted to an academic hospital, suggesting that management strategies may differ by hospital setting. Mortality among those with respiratory failure and those requiring mechanical ventilation has dropped significantly. Our findings may underscore the importance of promoting early referral to an academic institution and adherence to international treatment guidelines.http://link.springer.com/article/10.1186/s12890-020-01328-yIdiopathic pulmonary fibrosisMortalityAcademic hospitalRespiratory failureMechanical ventilation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shehabaldin Alqalyoobi Evans R. Fernández Pérez Justin M. Oldham |
spellingShingle |
Shehabaldin Alqalyoobi Evans R. Fernández Pérez Justin M. Oldham In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programs BMC Pulmonary Medicine Idiopathic pulmonary fibrosis Mortality Academic hospital Respiratory failure Mechanical ventilation |
author_facet |
Shehabaldin Alqalyoobi Evans R. Fernández Pérez Justin M. Oldham |
author_sort |
Shehabaldin Alqalyoobi |
title |
In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programs |
title_short |
In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programs |
title_full |
In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programs |
title_fullStr |
In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programs |
title_full_unstemmed |
In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programs |
title_sort |
in-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the united states between 2013-2017: a comparison of academic and non-academic programs |
publisher |
BMC |
series |
BMC Pulmonary Medicine |
issn |
1471-2466 |
publishDate |
2020-11-01 |
description |
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a devastating condition characterized by progressive lung function decline and early mortality. While early accurate diagnosis is essential for IPF treatment, data evaluating the impact of hospital academic status on IPF-related mortality remains limited. Here we examined in-hospital mortality trends for patients with IPF from 2013 to 2017. We hypothesized that in-hospital IPF mortality would be influenced by hospital academic setting. Methods Hospitalization data was extracted from the National Inpatient Sample (NIS) for subjects with an international classification of disease code for IPF. In-hospital mortality stratified by hospital setting (academic versus non-academic) was the primary outcome of interest, with secondary analyses performed for subgroups with and without respiratory failure and requiring mechanical ventilation. Predictors of mortality were then assessed. Results Among 93,680 patients with IPF requiring hospitalization, 58,450 (62.4%) were admitted to academic institutions. In-hospital mortality decreased significantly in those admitted to an academic hospital (p < 0.001) but remained unchanged in patients admitted to a non-academic hospital. A plateau in-hospital mortality was observed among all hospitalized patients (p = 0.12), with a significant decrease observed for patients with admitted respiratory failure (p < 0.001) and those placed on mechanic ventilation (p < 0.001). Conclusion In-hospital mortality decreased significantly for patients with IPF admitted to an academic hospital, suggesting that management strategies may differ by hospital setting. Mortality among those with respiratory failure and those requiring mechanical ventilation has dropped significantly. Our findings may underscore the importance of promoting early referral to an academic institution and adherence to international treatment guidelines. |
topic |
Idiopathic pulmonary fibrosis Mortality Academic hospital Respiratory failure Mechanical ventilation |
url |
http://link.springer.com/article/10.1186/s12890-020-01328-y |
work_keys_str_mv |
AT shehabaldinalqalyoobi inhospitalmortalitytrendsamongpatientswithidiopathicpulmonaryfibrosisintheunitedstatesbetween20132017acomparisonofacademicandnonacademicprograms AT evansrfernandezperez inhospitalmortalitytrendsamongpatientswithidiopathicpulmonaryfibrosisintheunitedstatesbetween20132017acomparisonofacademicandnonacademicprograms AT justinmoldham inhospitalmortalitytrendsamongpatientswithidiopathicpulmonaryfibrosisintheunitedstatesbetween20132017acomparisonofacademicandnonacademicprograms |
_version_ |
1724429780964605952 |